My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Eli Lilly (NY:LLY)

1,076.98 +5.34 (+0.50%)

Official Closing Price Updated: 5:00 PM EST, Dec 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

99 100 Next >

Trump Issues 60 Day Ultimatum To US Pharma Giants To Slash Drug Prices: 'If You Refuse To Step Up We Will...' ↗

August 01, 2025

President Donald Trump has issued a 60-day ultimatum to 17 major pharmaceutical companies, demanding that they lower drug prices in the U.S. or face severe consequences.

Via Benzinga

Topics Government

Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch ↗

July 31, 2025

Via Stocktwits

Topics Government

Trump To Issue 60-Day Warning Letters To Drugmakers Over Pricing ↗

July 31, 2025

The U.S. President is expected to send out these letters through his social media platform, Truth Social.

Via Stocktwits

Topics Government Regulatory Compliance

If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today ↗

July 31, 2025

Via Benzinga

Eli Lilly's Options Frenzy: What You Need to Know ↗

July 25, 2025

Via Benzinga

Should You Buy Pfizer (PFE) Stock Before August 5? Here's What History Says ↗

July 31, 2025

Pfizer presents a good buying opportunity, but not because of potential earnings.

Via The Motley Fool

Topics Supply Chain

Eli Lilly Obesity Drug Mounjaro Beats Legacy Trulicity On Cardio-Renal Health ↗

July 31, 2025

Eli Lilly's Mounjaro matched Trulicity in heart outcomes and showed added benefits on A1C, weight, kidney function, and mortality in a major trial.

Via Benzinga

Novo Nordisk Hit With Stock Downgrades After Lowering Full-Year Outlook: But Retail Is Optimistic On Company’s Profitability ↗

July 30, 2025

Barclays downgraded Novo to ‘Equal Weight’ from ‘Overweight’ with a price target of DKK 375, down from DKK 700.

Via Stocktwits

Novo Nordisk Stock Hits New 52-Week Low Amid Profit Warning: What Investors Need To Know ↗

July 30, 2025

Shares of Novo Nordisk are trading lower Wednesday morning. The stock is extending a dramatic sell-off from Tuesday's session.

Via Benzinga

Why Eli Lilly Stock Was Looking Sickly Today ↗

July 29, 2025

It seemed the market overreacted to discouraging news from one of the company's rivals.

Via The Motley Fool

History of Novo Nordisk A/S Stock: From Insulin Pioneers to Global Pharma Leader (NYSE:NVO)

July 29, 2025

Novo Nordisk A/S (NYSE:NVO) has evolved over the past century from a humble insulin manufacturer in Denmark into one of the world’s most valuable pharmaceutical companies. With a commanding presence in...

Via MarketMinute

Topics Economy Emissions

Lucid Signs Up Timothée Chalamet As Global Brand Ambassador: Retail Terms It A Desperate Cash-Draining Move ↗

July 29, 2025

Chalamet will headline Lucid’s new marketing campaign for its Gravity SUV later this year.

Via Stocktwits

Novo Nordisk Shares Plunge Amid Leadership Shakeup (NYSE:NVO)

July 29, 2025

In a surprising turn of events, shares of pharmaceutical giant Novo Nordisk (NYSE:NVO) fell sharply following the company’s announcement of a significant leadership restructuring. The abrupt changes at...

Via MarketMinute

Topics ETFs Economy

Why Eli Lilly (LLY) Stock Is Falling Today

July 29, 2025

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 4.3% in the morning session after its key competitor in the weight-loss drug market, Novo Nordisk, lowered its sales and profit growth...

Via StockStory

Eli Lilly’s Cancer Drug Demonstrates Better Effectiveness Than AbbVie’s In Late Stage Trial: Retail Believes In Holding The Stock ↗

July 29, 2025

Jaypirca had an overall response rate better than AbbVie’s Imbruvica in the study, meaning a higher percentage of patients treated with Jaypirca experienced their cancer shrink or disappear after...

Via Stocktwits

What's Going On With Eli Lilly Stock On Tuesday? ↗

July 29, 2025

Eli Lilly stock slips after Novo Nordisk trims 2025 forecast; Jaypirca meets endpoint in CLL trial against J&J's Imbruvica, with more data expected.

Via Benzinga

3 Vanguard ETFs to Buy With $1,000 and Hold Forever ↗

July 29, 2025

A few investments can expose investors to top companies from across the globe.

Via The Motley Fool

Topics ETFs Economy

Eli Lilly Options Trading: A Deep Dive into Market Sentiment ↗

July 29, 2025

Via Benzinga

Novo Nordisk Implodes After Wegovy Warning—Is The Weight-Loss Bubble Bursting? ↗

July 29, 2025

Novo Nordisk stock collapsed 26% in its worst trading day ever after slashing guidance on Wegovy sales and naming a new CEO.

Via Benzinga

Drug Prices To Get 'More Expensive' Under Trump's EU Trade Deal As Pharma Faces Billions In Added Costs: Report ↗

July 29, 2025

The pharmaceutical industry could face a significant financial hit due to the new trade deal between the U.S. and the European Union (EU), potentially leading to increased drug prices and restricted...

Via Benzinga

Topics Government

Which S&P500 stocks are moving before the opening bell on Tuesday? ↗

July 29, 2025

Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.

Via Chartmill

Robert Kennedy Jr Blasts Vaccine Injury Compensation Program: 'Devolved Into A Morass Of Inefficiency, Favoritism, And Outright Corruption' ↗

July 28, 2025

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. is pledging a major overhaul of the National Vaccine Injury Compensation Program (VICP), describing the system as fundamentally broken...

Via Benzinga

AI Is Driving Healthtech Investments To New Heights, But Watch These 3 Overlooked Areas ↗

July 28, 2025

Via Benzinga

Topics Artificial Intelligence

Roche Bets Big On Alzheimer’s Prevention With New Trial As Duchenne Drug Setback Looms ↗

July 27, 2025

The pharma company is advancing a third late-stage study of its experimental Alzheimer’s drug trontinemab, which uses brain shuttle technology to bypass the blood-brain barrier and clear amyloid...

Via Stocktwits

Could GLP-1 Drugs Potentially Help Treat Cancer? 1 Promising Study Suggests They Might ↗

July 26, 2025

Via The Motley Fool

Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pills ↗

July 26, 2025

Sci-fi becomes reality: AI-native pharma disruptors like Palantir, Tempus, and Recursion are reshaping medicine. But ETFs still favor old-school giants.

Via Benzinga

Topics Artificial Intelligence ETFs

5 Dividend Stocks to Hold for the Next 20 Years ↗

July 25, 2025

Discover five unstoppable dividend stocks that could pay you for life, and why I wouldn't sell any of them!

Via The Motley Fool

Biotech Is Booming, and This Undervalued REIT Stands to Gain ↗

July 25, 2025

Via The Motley Fool

Congress Sounds Alarm Over Illegal Weight-Loss Drug Imports From China ↗

July 25, 2025

More than 80 U.S. lawmakers asked the FDA to stop counterfeit GLP-1 drugs linked to Chinese suppliers from entering the American market.

Via Benzinga

Topics Law Enforcement Supply Chain

3 Pharma Stocks That Aren't Sweating the Coming 200% Drug Tariffs ↗

July 25, 2025

US President Trump imposed 200% tariff on pharmaceuticals affecting US drug prices and supply chain, but analysts say it may not happen soon.

Via Benzinga

Topics Economy Government World Trade

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.